Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr John Hanley.

Newcastle AuthorsTitleYearFull text
Dr Tina Biss
Dr John Hanley
Therapeutic metamorphosis: Findings from a grounded theory study of the impact of low-dose prophylaxis in children living with haemophilia in India2020
Dr Seun Anyiam
Dr Maria McKenna
Dr John Hanley
Junior doctor teaching delivered by near peers2018
Dr Emma Kampouraki
Dr Peter Avery
Dr Hilary Wynne
Dr Tina Biss
Dr John Hanley
et al.
Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: A randomised clinical trial2017
Dr John Hanley
Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline2017
Dr Louise MacDougall
Dr John Hanley
Dr Nicholas Thompson
UK practice in the prevention of central venous catheter-associated thrombosis in adults on home parenteral nutrition2017
Dr John Hanley
Dr Katherine Talks
Dr Tina Biss
Paul Fearon
Bilateral upper limb compartment syndrome induced by strenuous exercise in a patient with haemophilia A and a low titre inhibitor2015
Dr John Hanley
Dr Tina Biss
Dr Katherine Talks
Colin Wilson
Interventions for preventing thrombosis in solid organ transplant recipients2015
Professor Farhad Kamali
Dr Hilary Wynne
Dr Patrick Kesteven
Dr John Hanley
Dr Jing Shen
et al.
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K2013
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Dr John Hanley
Professor Ann Daly
et al.
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children2011
Dr John Hanley
A United Kingdom haemophilia centre doctors' organization guideline approved by the British committee for standards in haematology: Guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A2010
Dr Montserrat Briz Del Blanco
Dr Katherine Talks
Dr John Hanley
Dr Patrick Kesteven
Professor Ann Daly
et al.
Reversal of warfarin-induced over-anticoagulation with individualized dosing of oral vitamin K: a pilot study2010
Dr Valerie Wilson
Dr John Hanley
Dr Katherine Talks
Dr Ann Curtis
Evaluation of a diagnostic service for haemophilia A incorporating the LightScanner high resolution melt analysis system2009
Dr Katherine Talks
Dr John Hanley
Dr Patrick Kesteven
Dr Peter Avery
Professor Ann Daly
et al.
Individualised oral vitamin K for reversal of warfarin excessive anticoagulation2009
Dr Mark Baker
Dr John Hanley
Emeritus Professor Doug Turnbull
Andrew Loughney
Hyperemesis gravidarum and first trimester sagittal sinus thrombosis2008
Dr Patrick Kesteven
Dr Katherine Talks
Dr John Hanley
A retrospective audit of a standard protocol for the rapid reversal of warfarin in patients with intracranial haemorrhage2007
Dr John Hanley
Proposed management of pregnancy and labour in an inherited platelet disorder, Glanzmann's thrombasthenia2007
Dr Tina Biss
Dr John Hanley
Use of recombinant factor VIIa (rFVIIa) in the management of intractable haemorrhage - A survey of current UK practice2007
Dr John Hanley
An audit of thrombophilia screens: results from the National Pathology Alliance benchmarking review2006
Dr Tina Biss
Dr John Hanley
Clinical scoring systems to guide the use of recombinant activated factor VII (rFVIIa) in major haemorrhage2006
Dr Tina Biss
Dr Mark Velangi
Dr John Hanley
Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature2006
Diana Levett
Professor Roderick Skinner
Emeritus Professor Andy Hall
Dr John Hanley
Novel mutations in a child with congenital amegakaryocytic thrombocytopenia2006
Dr Tina Biss
Dr John Hanley
Recombinant activated factor VII (rFVIIa/NovoSevenĀ®) in intractable haemorrhage: Use of a clinical scoring system to predict outcome2006
Dr Tina Biss
Dr John Hanley
Andrew Loughney
Recombinant activated factor VII in the management of major obstetric haemorrhage2006
Andrew Loughney
Professor Roy Taylor
Dr John Hanley
The treatment of acute venous thromboembolism (VTE) in pregnancy. A retrospective study of experience in a single centre over 8 years2005
Dr Tina Biss
Dr John Hanley
The use of recombinant factor VIIa in the management of major haemorrhage: Experience within the northern region of the UK2005
Dr Arun Natarajan
Emerita Professor Sally Marshall
Dr John Hanley
Professor Azfar Zaman
Thrombogenicity of flowing blood is increased in patients with type 2 diabetes mellitus (T2DM) despite treatment with aspirin2005
Dr John Hanley
UKHCDO acquired haemophilia study: A complete national cohort2005
Dr John Hanley
Warfarin reversal2004
Dr Tina Biss
Dr Lucy Crossman
Dr John Hanley
An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhage2003
Dr Jonathan Wallis
Dr John Hanley
Chronic relapsing thrombotic thrombocytopenic purpura due to a deficiency of von Willebrand factor-cleaving protease activity2002
Diana Levett
Emeritus Professor Andy Hall
Dr John Hanley
Professor Julie Irving
Comparitive study of conformation sensitive gel electrophoresis (CSGE) and denaturing high pressure liquid chromatography (DHPLC) for mutation detection in von Willebrands disease2002
Dr John Hanley
The use of recombinant factor VIIA in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage2002